The Philippines FDA has issued a draft administrative order to officially adopt and implement the ASEAN mutual recognition agreement for BE study reports of generic medicinal products.
The MRA aims to facilitate the movement of generic products in the ASEAN region.
It enables BE study reports, issued by ASEAN-listed BE centers, to be mutually recognized across member states to support national reviews.
The FDA order outlines general rules, regulations, and guidelines for BE study reports and on the listing of BE centers.

Philippines Seeks Feedback On Plan To Recognize BE Studies Under ASEAN Deal

More from Generics